Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

@article{Ferm2006LongtermRA,
  title={Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).},
  author={C. Ferm{\'e} and N. Mounier and O. Casasnovas and P. Brice and M. Divin{\'e} and A. Sonet and Fahdela Bouafia and Aspasia Bastard-Stamatoullas and D. Bordessoule and L. Voillat and O. Reman and M. Blanc and C. Gisselbrecht},
  journal={Blood},
  year={2006},
  volume={107 12},
  pages={
          4636-42
        }
}
From 1989 to 1996, 533 eligible patients with stage IIIB/IV Hodgkin lymphoma (HL) were randomly assigned to receive 6 cycles of hybrid MOPP/ABV (mechlorethamine, vincristine, procarbazine, prednisone/Adriamycin [doxorubicin], bleomycin, vinblastine; n = 266) or ABVPP (doxorubicin, bleomycin, vinblastine, procarbazine, prednisone; n = 267). Patients in complete remission (CR) or partial response of at least 75% after 6 cycles received 2 cycles of consolidation chemotherapy (CT) (n = 208) or… Expand
45 Citations
Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapy.
  • 7
A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: Results of a phase II study of the Groupe d'Études des Lymphomes de l'Adulte (GELA)
  • C. Fermé, P. Brice, +8 authors for the Groupe d'Études des Lymphomes de l'Adulte,
  • Medicine
  • Leukemia & lymphoma
  • 2007
  • 6
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
  • 59
Treatment of advanced-stage Hodgkin lymphoma.
  • 17
The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future
  • 9
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
  • 431
  • PDF
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
  • 350
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
  • 732
  • PDF
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV A & B Hodgkin's disease.
  • 30
Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease.
  • 149
Long-term follow-up of Hodgkin's disease trial.
  • 128
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.
  • 34
Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?
  • S. Laskar, T. Gupta, +5 authors K. Dinshaw
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2004
  • 164
...
1
2
3
4
...